Our ability to provide in-depth assessments of the functions of white blood cells forms the basis of disease diagnosis. Combining LAFA results with AI, we are able to achieve >95% accuracy in differentiating infectious and non-infectious septic shock.
Leukocyte adhesion is a key step in immune-mediated inflammatory response. The LAFA technology provides quantitative measurement of cell adhesion which allows accurate measurement of drug efficacy from different individuals.
The LAFA technology provides a versatile platform catering to different drug development needs. The customised LAFA test mimics specific diseases and tissue microenvironment, which provides insightful feedback in drug efficacy and dose-response.
The LAFA technology supports a wide range of animal models (such as mice, rats, and bovines). Our research team is ready to help you with your next grant proposal and your ground-breaking research.